期刊文献+

脂肪因子Chemerin在非酒精性脂肪肝中的临床意义

Clinical significance of chemerin in Nonalcoholic fatty liver disease
原文传递
导出
摘要 目的探讨非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)患者血清chemerin水平的变化及临床意义。方法选择2010年5月—2011年6月NAFLD患者46例,轻度24例B组,中重度22例C组,正常对照组26例A组,分别检测各组空腹血糖(FBS)、胰岛素(FINS)、血脂、chemerin水平及体质指标。甘油三酯、空腹胰岛素、HOMA-IR、chemerin均经对数(lg10)转换使之正态化后再分析。采用方差分析、相关分析、偏相关分析以及多元线性回归分析,P<0.05为差异有统计学意义。结果三组中的收缩压、舒张压均无明显差异(均P>0.05)。NAFLD组(B+C组)WC、WHR、BMI、FBS、FINS、HOMA-IR、TG、TC、LDL-C、Chemerin水平均显著高于正常对照组(均P<0.05);HDL-C水平显著低于正常对照组(P<0.05);而中重度NAFLD组(C组)BMI、FINS、TG、HOMA-IR、Chemerin水平均显著高于轻度NAFLD组(均P<0.05)。应用Pearson相关性分析显示,血清Chemerin水平与BMI(r=0.482)、WHR(r=0.421)、TG(r=0.390)、HOMA-IR(r=0.329)、FINS(r=0.301)、TC(r=0.287)LDL-C(r=0.253)正相关,与HDL-C(r=-0.316)负相关(P<0.05)。以是否患NAFLD为应变量,以WC、WHR、BMI、FBS、FINS、HOMA-IR、TG、TC、LDL-C、Chemerin为自变量,进行逐步回归分析。结果显示TG、Chemerin、进入方程,Y=31.533+1.372*TG+0.864*Chemerin。结论 NAFLD患者中血清Chemerin水平增加,在NAFLD的发生发展中具有重要的意义。 Objective To discuss the serum level of chemerin in nonalcoholic fatty liver disease(NAFLD)and its clinical significance.Methods From May 2010 until June 2011,46 patients with NAFLD were selected and divided into mild group(n=24),moderate to severe group(n=22)and control group(n=26).All patients were tested for FBS,FINS,blood lipids,chemerin levels,and body mass index.After logarithm transformation,triglycerides,fasting insulin,HOMA-IR and chemerin(LG10) were in normalization and were analyzed afterwards.Analysis of variance,correlation analysis,partial correlation analysis and multiple linear regression analysis were used,the result of P〈0.05 was considered statistically significant.Results No significant difference was found in systolic blood pressure and diastolic blood pressure among three groups(all P〈0.05).Compared with control group,the parameter levels of NAFLD group such as WC,WHR,BMI,FBS,FINS,HOMA-IR,TG,TC,LDL-C and chemerin were markedly higher(P〈0.05);HDL-C levels were significantly lower(P〈0.05).The levels of BMI,FINS,TG,HOMA-IR and chemerin were significantly higher in moderate to severe group than in mid group(P〈0.05).Pearson relation analysis showed that chemerin levels were positively correlated with BMI,WHR,TG,HOMA-IR,FINS,TC,LDL-C and LDL-C,and negatively correlated with HDL-C(P〈0.05).Stepwise regression analysis was carried out on the basis that suffering from NAFLD served as a dependent variable,while WC,WHR,BMI,FBS,FINS,HOMA-IR,TG,TC,LDL-C and Chemerin as independent variables.Conclusions Chemerin levels increase obviously in patients with NAFLD,which is of great significance to the development of NAFLD.
出处 《社区医学杂志》 2013年第10期1-3,共3页 Journal Of Community Medicine
基金 山东省自然科学基金(ZR2009CM065)
关键词 CHEMERIN 非酒精性脂肪肝 胰岛素抵抗 Chemerin Nonalcoholic fatty liver disease Insulin resistance
  • 相关文献

参考文献10

  • 1Almeda - Valdas P, Cuevas - Ramos D, Aguilar - Salinas CA. Meta- bolic syndrome and non - alcoholic fatty liver disease[ J]. Ann Hepa- tol,2009,8 ( Suppl1 ) : 18 -24.
  • 2Ernst MC,Sinal CJ. Chemerin:at the crossroads of inflammation and obesity[ J]. Trends Endocrinol Metab ,2010,21 ( 11 ) :660 - 667.
  • 3Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipo- kine associatedwith obesity and metabolic syndrome[ J ]. Endocrinolo- gy,2007,148:4687 - 4694.
  • 4非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. 被引量:1165
  • 5Brunt EM, Janncy CG, Di Bisceglie AM, et al. Nonalcoholic steato- hepatitis :a proposal for grading and staging the histological lesions [ J ]. Am J Gastroentero, 1999,194:2467 - 2474.
  • 6Perez M, Gonzdles L, Olarte R, et al. Nonalcoholic fatty liver disease is associated with insulin resistance in ayoung Hispanic population [ J]. Prey Med ,2011,52 : 174 - 177.
  • 7Ress C,Tschoner A, Engl J,et al. Effect of bariatric surgery on circu- lating chemerin levels [ J ]. Eur J Clin Invest, 2010,40 ( 3 ) : 277 - 280.
  • 8Tan BK, Chen J, Farhatullah S, et al. Insulin and mefformin regulate circulating and adipose tissue chemerin [ J ]. Diabetes,2009,58 (9) : 1971 - 1977.
  • 9De Taeye BM, Novit skaya T, MeGuinness OP, et al. Maerephage TNF - a contributes to insulin resistance and hepatic steatosis in diet - induced obesity [ J ]. Am J Physiol Endocrinol Metab, 2007,293 : 713 -725.
  • 10Kukla M, Zwirska - Korczala K, Hartleb M, et al. Serum Chemerin and vaspin in non -alcoholic fatty liver disease[ J]. Scand J Gastro- enterol,2010,45 (2) :235 - 242.

二级参考文献3

共引文献1164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部